scholarly journals The Relationship of Serum Soluble Fas Ligand (sFasL) Level with the Extent of Coronary Artery Disease

2012 ◽  
Vol 21 (01) ◽  
pp. 029-034 ◽  
Author(s):  
Asife Sahinarslan ◽  
Bulent Boyaci ◽  
Sinan Kocaman ◽  
Salih Topal ◽  
Ugur Ercin ◽  
...  
2008 ◽  
Vol 201 (2) ◽  
pp. 407-412 ◽  
Author(s):  
Luis M. Blanco-Colio ◽  
José L. Martín-Ventura ◽  
José Tuñón ◽  
Tamara García-Camarero ◽  
José R. Berrazueta ◽  
...  

2014 ◽  
Vol 233 (2) ◽  
pp. 616-622 ◽  
Author(s):  
Aleksander Szymanowski ◽  
Wei Li ◽  
Anna Lundberg ◽  
Chamilly Evaldsson ◽  
Lennart Nilsson ◽  
...  

2008 ◽  
Vol 9 (1) ◽  
pp. 184 ◽  
Author(s):  
L. Blanco-Colio ◽  
J. Martin-Ventura ◽  
J. Tunon ◽  
T. Garcia-Camarero ◽  
J. Berrazueta ◽  
...  

PEDIATRICS ◽  
1962 ◽  
Vol 29 (4) ◽  
pp. 566-578
Author(s):  
George Bialkin ◽  
Saul Zucker ◽  
Burton S. Sklarin ◽  
Kurt Hirschhorn ◽  
Murray Davidson

A family consisting of a mother and father, heterozygous for idiopathic hyperlipemia, and their four offspring, one heterozygous and three homozygous for the disease, are described. In addition, a fifth child who is heterozygous, born of same mother but by another incompletely studied father, is presented. The genetics of the disease in this family, and also in the general population, with emphasis on diagnosis and prognosis in heterozygotes is discussed. The interrelationship of various lipid components in serum and their metabolism are briefly reviewed. The possible defective mechanisms in hyperlipemia, the techniques for deciding on the specific defect, and their application to the members of this family are reviewed. The effect of heparin, nicotinic acid, and fat-free diets in the homozygous members of the family are evaluated and their therapeutic applications are discussed. The symptomatology, possible pathologic physiology, relationship to lipid levels in serum and occurrence of abdominal crises in some of the homozygous members of this family are pointed out. The relationship of cholesterol and triglyceride levels in serum to, and the significance of, idiopathic hyperlipemia in the genesis of, atherosclerosis and coronary artery disease is elucidated.


2018 ◽  
Vol 10 (2) ◽  
pp. 70-75 ◽  
Author(s):  
Turgut Karabağ ◽  
Emіne Altuntaş ◽  
Belma Kalaycı ◽  
Bahar Şahіn ◽  
Mustafa Umut Somuncu ◽  
...  

Cardiology ◽  
1979 ◽  
Vol 64 (1) ◽  
pp. 48-57 ◽  
Author(s):  
Fulvío Pileggi ◽  
Paulo Roberto Camargo ◽  
Egas Armelin ◽  
Giovanni Bellotti ◽  
Protásio da Luz ◽  
...  

2021 ◽  
Author(s):  
Xinyi Zhang ◽  
Sicong Li ◽  
Yuxuan Zhao ◽  
Ningjia Tang ◽  
Tong Jia ◽  
...  

Aim: The aim of this study was to assess the association between PEAR1 polymorphisms and ischemic clinical outcomes. Materials & methods: We searched the electronic database for articles on the relationship of PEAR1 SNPs and ischemic events in patients with coronary artery disease (CAD) up to October 2020. Results: A total of 9914 patients with CAD from six studies focusing on 12 SNPs of PEAR1 were included in this study. The A allele of rs12041331 were associated with ischemic events (odds ratio: 1.40; 95% CI: 1.04–1.88; p = 0.03). The AA homozygotes of rs2768759 was related to a higher risk of ischemic events than carriers of the C allele (odds ratio: 2.08; 95% CI: 1.09–3.97; p = 0.03). Conclusion: PEAR1 rs12041331 and rs2768759 are significantly associated with ischemic events in patients with CAD.


Antioxidants ◽  
2019 ◽  
Vol 8 (10) ◽  
pp. 484 ◽  
Author(s):  
Victor J. van den Berg ◽  
Maxime M. Vroegindewey ◽  
Isabella Kardys ◽  
Eric Boersma ◽  
Dorian Haskard ◽  
...  

Antibodies to oxidized LDL (oxLDL) may be associated with improved outcomes in cardiovascular disease. However, analysis is restricted by heterogenous study design and endpoints. Our objective was to conduct a comprehensive systematic review assessing anti-oxLDL antibodies in relation to coronary artery disease (CAD). Through a systematic literature search, we identified all studies assessing the relationship of either, IgG or IgM ox-LDL/ copper-oxLDL/ malondialdehyde-LDL, with coronary atherosclerosis or cardiovascular events in populations with, and without, established CAD. Systematic review best practices were adhered to and study quality was assessed. An initial electronic database search identified 2059 records, which was subsequently followed by abstract and full-text review. Finally, we included 18 studies with over 1811 patients with CAD. The studies varied according to populations studied, conventional cardiovascular risk factors and interventional modalities used to assess CAD. IgM anti-oxLDL antibodies were found to indicate protection from more severe CAD and possibly cardiovascular events, whilst the relationship with IgG is more complex and difficult to elucidate, with studies reporting divergent results. In this systematic review, there is evidence that suggests a relationship between anti-oxLDL antibodies and CAD, especially for the IgM subclass. However, further studies, with well-characterized prospective cohorts, will be important to clarify these associations.


Sign in / Sign up

Export Citation Format

Share Document